Richmond, TX, United States of America

Joshua Kellner

This inventor holds 1 USPTO granted patent. Top assignee: The George Washington University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joshua Kellner. Retrieved from https://idiyas.com/inventor/joshua-kellner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cryopreservation by Joshua Kellner

Introduction

Joshua Kellner is an innovative inventor based in Richmond, TX (US). He has made significant contributions to the field of cryopreservation, particularly in the context of cell therapies. His work focuses on developing methods and compositions that enhance the preservation of cellular materials.

Latest Patents

Kellner holds a patent for "Methods and compositions for cryopreservation of cell therapies." This patent outlines various cryopreservation compositions and methods that are essential for the freezing and thawing processes of cell therapies. The disclosure provides insights into systems designed for effective cryopreservation, ensuring the viability of cell therapies during storage and transport.

Career Highlights

Joshua Kellner is affiliated with Washington University, where he continues to advance research in cryopreservation techniques. His work is pivotal in improving the efficacy of cell therapies, which have the potential to revolutionize medical treatments.

Collaborations

Kellner collaborates with Eric Yvon, contributing to the development of innovative solutions in the field of cryopreservation. Their combined expertise enhances the research and application of cell therapies.

Conclusion

Joshua Kellner's contributions to cryopreservation represent a significant advancement in the field of cell therapies. His innovative methods and compositions are crucial for the future of medical treatments involving cellular materials.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…